Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZFHX3 antisense RNA 3 (ZFHX3-AS3) is an uncharacterized long non-coding RNA, transcribed antisense to the ZFHX3 gene. The ZFHX3 gene itself encodes a transcription factor known as Zinc finger homeobox 3 (also called ATBF1), which plays critical roles in transcriptional regulation, circadian rhythm, neuronal and myogenic differentiation, and tumor suppression[5][4][1]. However, no structured or peer-reviewed information is available about the biological functions, molecular interactions, or disease relevance of ZFHX3-AS3 specifically. It is not currently recognized as a therapeutic target, clinical biomarker, or drug-interacting entity in the biomedical literature[5][4]. The absence of characterization, interaction studies, or therapeutic targeting makes it scientifically inaccurate to treat ZFHX3-AS3 as a validated target. If you require structured data for ZFHX3 (the protein-coding gene and its product, Zinc finger homeobox 3), refer to the abundance of detailed literature on ZFHX3. For ZFHX3-AS3, all fields beyond name, classification (lncRNA), and aliases should be considered null or "not characterized" for structured information extraction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZFHX3 antisense RNA 3 (ZFHX3-AS3).